NDC 10144-342

Inbrija

Levodopa

Inbrija is a Respiratory (inhalation) Capsule in the Human Prescription Drug category. It is labeled and distributed by Acorda Therapeutics, Inc.. The primary component is Levodopa.

Product ID10144-342_7e95ddcc-7fe7-8b52-e053-2a91aa0a2984
NDC10144-342
Product TypeHuman Prescription Drug
Proprietary NameInbrija
Generic NameLevodopa
Dosage FormCapsule
Route of AdministrationRESPIRATORY (INHALATION)
Marketing Start Date2018-12-22
Marketing CategoryNDA / NDA
Application NumberNDA209184
Labeler NameAcorda Therapeutics, Inc.
Substance NameLEVODOPA
Active Ingredient Strength42 mg/1
Pharm ClassesAromatic Amino Acid [EPC],Amino Acids, Aromatic [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 10144-342-04

1 BLISTER PACK in 1 CARTON (10144-342-04) > 4 CAPSULE in 1 BLISTER PACK (10144-342-01)
Marketing Start Date2019-08-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 10144-342-12 [10144034212]

Inbrija CAPSULE
Marketing CategoryNDA
Application NumberNDA209184
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-08-29

NDC 10144-342-60 [10144034260]

Inbrija CAPSULE
Marketing CategoryNDA
Application NumberNDA209184
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-12-22

NDC 10144-342-92 [10144034292]

Inbrija CAPSULE
Marketing CategoryNDA
Application NumberNDA209184
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-12-22

NDC 10144-342-32 [10144034232]

Inbrija CAPSULE
Marketing CategoryNDA
Application NumberNDA209184
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-12-22

NDC 10144-342-16 [10144034216]

Inbrija CAPSULE
Marketing CategoryNDA
Application NumberNDA209184
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-12-22

NDC 10144-342-04 [10144034204]

Inbrija CAPSULE
Marketing CategoryNDA
Application NumberNDA209184
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-08-29

NDC 10144-342-01 [10144034201]

Inbrija CAPSULE
Marketing CategoryNDA
Application NumberNDA209184
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-12-22

Drug Details

Active Ingredients

IngredientStrength
LEVODOPA42 mg/1

OpenFDA Data

SPL SET ID:a906f8e1-6e1c-480a-8276-c01bc65dd3be
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 2107616
  • 2107621

    • Pharmacological Class

    • Aromatic Amino Acid [EPC]
    • Amino Acids
    • Aromatic [CS]

    Trademark Results [Inbrija]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    INBRIJA
    INBRIJA
    87980717 5875276 Live/Registered
    ACORDA THERAPEUTICS, INC.
    2017-05-26
    INBRIJA
    INBRIJA
    87465405 not registered Live/Pending
    ACORDA THERAPEUTICS, INC.
    2017-05-26
    INBRIJA
    INBRIJA
    87465372 not registered Live/Pending
    ACORDA THERAPEUTICS, INC.
    2017-05-26
    INBRIJA
    INBRIJA
    86717358 not registered Live/Pending
    ACORDA THERAPEUTICS, INC.
    2015-08-06
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.